Endoxan 200 mg

Endoxan 200 mg is a medicine authorised by Swissmedic under authorisation number 25442. The authorisation holder is Baxter AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 October 1960 and the authorisation is valid without a time limit. ATC code L01AA01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 25442
  • ATC L01AA01
  • Synthetic medicines
Authorisation data
Authorisation number25442
NameEndoxan 200 mg
Full nameEndoxan 200 mg, Pulver zur Herstellung einer Infusionslösung
Authorisation holderBaxter AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01AA01
First authorisation25 October 1960
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Endoxan 200 mg, Pulver zur Herstellung einer InfusionslösungA25 October 1960
3Endoxan 1 g, Pulver zur Herstellung einer InfusionslösungA21 August 1964
4Endoxan 500 mg, Pulver zur Herstellung einer InfusionslösungA29 February 1988

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
751Durchstechflasche(n)L01AA0107.16.1.A
831Durchstechflasche(n)L01AA0107.16.1.A
911Durchstechflasche(n)L01AA0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Endoxan 200 mg authorised in Switzerland?

Yes. Endoxan 200 mg is authorised by Swissmedic under authorisation number 25442, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Endoxan 200 mg have?

Endoxan 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Endoxan 200 mg?

The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com